Acupuncture May Alleviate Nocturia in Men Treated for Prostate Cancer
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, June 3, 2025 -- Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May 29 in JAMA Oncology.
Kevin T. Liou, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a randomized trial to evaluate acupuncture (10 weekly standardized treatments) relative to usual care for nocturia in prostate cancer survivors. The analysis included 60 participants with treated prostate cancer who reported two or more nocturia episodes every night for the past month.
The researchers found that acupuncture (40 participants) produced greater reduction in nocturia episodes than the waiting-list control (20 participants) by the end of treatment at week 10 (between-group difference, −1.13), which persisted up to one month posttreatment (difference, −0.85). Acupuncture was also associated with greater reduction in International Prostate Symptom Score total scores versus control at week 10 (difference, −3.76), which persisted until week 14 (difference, −3.39). Among those assigned to acupuncture, the most common adverse events were dizziness (mild, 2) and insomnia (mild, 2), with no cases reported in the control group.
"The promising effects of acupuncture on nocturia warrant further investigation in larger trials to address a substantial unmet need among survivors of prostate cancer," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-04 12:00
Read more

- Shedding Pounds in Middle Age Could Add Years to Your Life, Study Finds
- Dr. Robert Jarvik, Inventor of First Human Artificial Heart, Dies at 79
- FDA Approves Starjemza (ustekinumab-hmny), a Biosimilar to Stelara
- U.S. FDA Accepts New Drug Application Under Priority Review for Sevabertinib (BAY 2927088) in HER2-Mutant Non-Small Cell Lung Cancer
- Can A Vegan Diet Reduce Menopause Symptoms?
- More Seniors Are Regular Weed Users
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions